Results 91 to 100 of about 38,669 (242)
DEN Open, Volume 6, Issue 1, April 2026.ABSTRACT Histological biopsy is essential for diagnosing ampullary tumors; however, it can occasionally result in severe adverse events. A 49‐year‐old male underwent esophagogastroduodenoscopic screening, which revealed an ampulla of Vater with enlargement of the oral protrusion.
Tetsushi Azami +8 more
wiley +1 more source
Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.ABSTRACT Background Adverse childhood experiences (ACEs) are stressful or traumatic events prior to age 18 that are known to have a lasting impact on individuals’ health and well‐being. There is a gap in understanding the relationship between ACEs and Other Life Stressors and health status for adults with sickle cell disease (SCD).
Marsha Treadwell +8 more
wiley +1 more source
American Journal of Hematology, Volume 101, Issue 2, Page 269-280, February 2026.ABSTRACT There is limited information regarding the contemporary real‐world clinical and financial burden of Medicaid enrollees with sickle cell disease (SCD) in the United States. Using the IBM MarketScan Medicaid database (7/2016–12/2020), individuals with ≥ 3 SCD diagnoses were matched 1:1 on age, gender, and race to individuals without SCD ...
Giovanna Tedesco Barcelos +4 more
wiley +1 more source
A Case of Drug‐Induced Pancreatitis
Clinical Case Reports, Volume 14, Issue 2, February 2026.ABSTRACT Drug‐induced pancreatitis (DIP) is a rare but important cause of acute abdominal pain, and ciprofloxacin‐associated cases are exceptionally uncommon. We report a 35‐year‐old woman with no significant medical history who developed severe epigastric pain radiating to the back, accompanied by nausea and vomiting, 3 days after initiating self ...
Muskan Shrestha +5 more
wiley +1 more source
P-EGS30 Audit of the management of patients presenting with gallstone pancreatitis during the COVID-19 pandemic [PDF]
, 2021 Christophe Thomas +2 more
openalex +1 more source
United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.ABSTRACT Background and aims No medications are currently approved for the prevention of recurrent acute pancreatitis. This trial evaluated whether naldemedine, a peripherally acting μ‐opioid receptor antagonist, reduces the risk of acute pancreatitis in patients with recurrent acute pancreatitis. Methods This was a multicentre, double‐blinded, placebo‐
Mathias E. Cook +13 more
wiley +1 more source
Investigation into the Pancreatic Pathogenesis of SFTSV across Multiple Levels
Advanced Science, Volume 13, Issue 1, 5 January 2026.A retrospective analysis revealed that 17.6% of severe fever with thrombocytopenia syndrome (SFTS) patients met the diagnostic criteria for clinically confirmed pancreatitis. Using human pancreatic organoids and murine models demonstrated that SFTSV exhibits a specific pancreatic tropism, leading to cell death and initiating a strong inflammatory ...
Xiaohan Liu +10 more
wiley +1 more source
GLP‐1 agonist‐associated presentations to unscheduled care: An opportunistic pilot study
British Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 312-316, January 2026.The impact of GLP‐1 or GIP/GLP‐1 receptor agonist use on unscheduled care is not well‐described. We conducted a prospective, observational study using opportunistic screening by clinicians as a first step to understanding the effect of GLP‐1 or GIP/GLP‐1 agonists on Emergency Department presentations and to guide future studies.
Oliver Thomas, James Michael Coulson
wiley +1 more source